Últimos Artículos de Endocrine Related Cancer
- HMGCS1 as a potential mediator of resistance to EZH2 inhibition via ferroptosis mediated by PI3K/AKT/mTOR pathway in the pancreatic neuroendocrine neoplasms
- Mobile elements in pituitary neuroendocrine tumors: integrative evidence and future directions
- Systematic review of the molecular basis for cavernous sinus invasion in somatotropinomas
- Proteomic signatures of adipocyte recruitment in breast cancer
- Phaeochromocytomas and paragangliomas harbour tumour-initiating SOX2+ stem cells
- NP-101 in combination with nivolumab and ipilimumab in metastatic extrapulmonary neuroendocrine carcinomas (EP-NECs): A pilot study
- Determinants of false-positive plasma free metanephrines and methoxytyramine: the role of medications and chronic disease
- Unravelling mesenteric fibrosis in small intestinal neuroendocrine tumours and implications for clinical management
- Updating ACC preclinical models: characterization of two new patient-derived cell lines
- Convergent IGF2 overexpression in pheochromocytoma/paraganglioma: insights from Beckwith–Wiedemann syndrome
- DLK1: a novel therapeutic target in cancer
- RET receptor tyrosine kinase architecture, assemblies, and activation
- DNA methylation and demethylation dynamics in pituitary neuroendocrine tumours
- Clinical relevance of HRD score in pheochromocytomas and paragangliomas: molecular cluster distribution and prognostic implications
- Ageing and pituitary neuroendocrine tumours (PitNETs): from bench to bedside
- Breast cancer metastasis in obesity: extracellular vesicles as drivers
- Characterization of small intestinal neuroendocrine tumorlets
- Reproductive and sexual sequelae of neuroendocrine tumour therapies: an under-recognised challenge
- Relationship between vascular density and microenvironment in medullary thyroid carcinoma
- Succinate dehydrogenase-deficient cancer cells have increased susceptibility to Ym155-induced DNA damage